ArticleBMC cancer2023

Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System.

Dong Hyuk Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.